GlassScriptPhysician profile
Tung M Ha
NPI 1902020738
$11,339.09
in general payments reported to CMS, 2019-2025
15 companies · $66.05 in 2025
The $66.05 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,420 · 2020: $386 · 2021: $238 · 2022: $497 · 2023: $565 · 2024: $166 · 2025: $66.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $8,909.47 | 2019 | |
| Medtronic, INC. | $815.36 | 2021-2024 | Stealthstation S8 Platform, Unid_pass, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $655.78 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $314.17 | 2023 | |
| Si-Bone, INC. | $224.95 | 2019-2022 | |
| Abbott Laboratories | $143.50 | 2022-2024 | Eterna |
| Surgalign Spine Technologies, INC. | $65.87 | 2019-2022 | |
| Integrity Implants INC. | $59.88 | 2019 | |
| Boston Scientific Corporation | $31.01 | 2024 | Wavewriter Alpha Prime 16 |
| Baxter Healthcare | $26.16 | 2025 | Floseal |
| Bioventus LLC | $26.09 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.32 | 2025 | |
| Stryker Corporation | $18.21 | 2019 | |
| Globus Medical, INC. | $15.57 | 2025 | Excelsius Gps |
| Augmedics INC. | $8.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tung Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.